Your session is about to expire
← Back to Search
Procedure
TriLift for Dry Eye and Eyelid Laxity
Verified Trial
N/A
Recruiting
Led By James G Chelnis, MD
Research Sponsored by Lumenis Be Ltd.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Could you come to Manhattan for 5 visits over 2 months?
Are you 22 years old or older?
Timeline
Screening 1 day
Treatment 1 month
Follow Up 1 month
Awards & highlights
No Placebo-Only Group
Summary
This trial showed that a combo of drugs & RF can help improve dry eye symptoms.
Who is the study for?
This trial is for adults over the age of 22 who experience eye irritation or dryness and can travel to Manhattan for five visits across two months. Specific details on exclusion criteria are not provided.
What is being tested?
The study is testing the TriLift device, which uses Dynamic Muscle Stimulation (DMSt) + Radiofrequency (RF) to potentially improve the quality of blinking in people with dry eye disease.
What are the potential side effects?
Potential side effects are not detailed in the information provided, but may typically include discomfort at the treatment site, mild swelling or redness, and temporary muscle twitching.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 1 day1 visit
Treatment ~ 1 month3 visits
Follow Up ~ 1 month1 visit
Screening ~ 1 day
Treatment ~ 1 month
Follow Up ~1 month
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Impaired blink quality
Other study objectives
Adverse events
BCVA
Blink rate
+9 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: TriLiftExperimental Treatment1 Intervention
Combination of Dynamic Muscle Stimulation and Radiofrequency
Find a Location
Logistics
Other reimbursement is provided
Other forms of reimbursement are provided for this trial.
Who is running the clinical trial?
Lumenis Be Ltd.Lead Sponsor
37 Previous Clinical Trials
1,383 Total Patients Enrolled
James G Chelnis, MDPrincipal InvestigatorManhattan Face and Eye
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:Research Study Groups:
This trial has the following groups:- Group 1: TriLift
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 1 Weeks to process to see if you qualify in this trial.
- Treatment: You will receive the treatment for 1 Months
- Follow Ups: You may be asked to continue sharing information regarding the trial for 1 Months after you stop receiving the treatment.
Dry Eye Syndrome Patient Testimony for trial: Trial Name: NCT05945069 — N/A